|
|||||
|
|
High levels of serum CA15‐3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non‐pathological complete response after neoadjuvant chemotherapy |
|
| Authors: | Yukie Fujimoto MD Tomoko Higuchi MD Arisa Nishimukai MD Yoshimasa Miyagawa MD Ayako Kira MD PhD Hiromi Ozawa MD Ayako Bun MD Michiko Imamura MD PhD Yasuo Miyoshi MD PhD |
| Affiliation: | Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan |
| Abstract: | |
| Keywords: | breast cancer CA15‐3 carcinoembryonic antigen (CEA) prognosis residual cancer tumor marker |